European Journal of Medical Research | |
Study of T Cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART | |
N Wu1  NH Brockmeyer3  A Skaletz-Rorowski3  A Potthoff3  S Hoextermann3  C Jin1  L Feng2  Y Jin1  N Weng1  C Shou1  | |
[1] State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;Department of Microbiology and Parasitology, College of Medicine, Zhejiang University, Hangzhou, China;Department of Dermatology, Venerology and Allergology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany | |
关键词: IL-7; T cell subsets; highly active antiretroviral therapy (HAART); HIV-1; | |
Others : 824659 DOI : 10.1186/2047-783X-16-11-473 |
|
received in 2011-12-21, accepted in 2011-05-23, 发布年份 2011 | |
【 摘 要 】
Objective
To study the changes in T cell subsets and IL-7 in HIV-1-infected patients after seven years of highly active antiretroviral therapy (HAART).
Methods
Seventy-five individuals were included in this study (25 with effective HAART, 18 with ineffective HAART, 17 untreated HIV+ patients, and 15 volunteers in the HIV negative control group). The counts of CD4+, CD8+, CD8/CD38+, and CD8/HLADR+ T cells as well as the IL-7 protein expression was measured at 5 time points during a period of seven years in patients starting HAART (baseline) and in the HIV negative control group. The expression of CD127 on CD3+ T cells was measured by flow cytometry at a single time point (after 7 years) in patients with HAART and was compared with untreated HIV+ patients and the HIV negative control group.
Results
At baseline CD4+ T cell counts of HIV-1-infected patients were lower than that in the control group (p < 0.01), whereas the CD8+, CD8/HLADR+ and CD8/CD38+ T cell counts were higher than those in the control group (p <0.01). After seven years of effective HAART, the CD4+ T cell counts had increased and the CD8+ T cell count had decreased, although not to the normal levels (p < 0.05). Both the CD8/HLADR+ and CD8/CD38+ T cell counts had gradually approached those of the control group (p > 0.05). In the ineffective HAART group, the CD8/CD38+ T cell count had not decreased significantly, and CD8/HLADR+ T cell count gradually decreased. Before treatment, IL-7 serum levels of patients were significantly higher than that in the control group (p < 0.01). After seven years of effective HAART, IL-7 levels had gradually decreased, but were still higher than in the control group (p < 0.01). The CD127 expression on CD3+ CD8+ T cells in effective HAART patients was higher than in untreated HIV+ patients (p < 0.05), but was lower than that in the control group (p < 0.05). CD127 expression on CD3+ CD4+ T cells was not significantly different among the control group, untreated HIV+ patients and effective HAART group.
Conclusion
After seven years of effective HAART, the quantity and capacity of T cell subsets and IL-7 in HIV-1-infected patients had been partially restored, and the abnormal immune activation has significantly diminished.
【 授权许可】
2011 I. Holzapfel Publishers
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140713042230120.pdf | 2354KB | download | |
Figure 7. | 75KB | Image | download |
Figure 7. | 75KB | Image | download |
Figure 6. | 77KB | Image | download |
Figure 6. | 77KB | Image | download |
Figure 5. | 87KB | Image | download |
Figure 5. | 87KB | Image | download |
Figure 4. | 38KB | Image | download |
Figure 4. | 38KB | Image | download |
Figure 3. | 41KB | Image | download |
Figure 3. | 41KB | Image | download |
Figure 2. | 51KB | Image | download |
Figure 2. | 51KB | Image | download |
Figure 1. | 61KB | Image | download |
Figure 1. | 61KB | Image | download |
【 图 表 】
Figure 1.
Figure 1.
Figure 2.
Figure 2.
Figure 3.
Figure 3.
Figure 4.
Figure 4.
Figure 5.
Figure 5.
Figure 6.
Figure 6.
Figure 7.
Figure 7.
【 参考文献 】
- [1]McCune JM: The dynamics of CD4+T cell depletion in HIV disease. Nature 2001, 410:974-979.
- [2]Louie M, Hogan C, Di Mascio M, et al.: Determining the relative efficacy of highly active antiretroviral therapy. J Infect Dis 2003, 187(6):896-900.
- [3]Bouscart F, Levacher-Clergeot M, Dazza MC, et al.: Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1996, 12:17-24.
- [4]Burgisser P, Hammann C, Kaufmann D, et al.: Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towads normalization under treatment. Clin Exp Immunol 1999, 115:458-463.
- [5]Koning FA, Otto SA, Hazenberg MD, et al.: Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 2005, 175(9):6117-6122.
- [6]Hughes R, Sterne J, Walsh J, et al.: Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study. HIV Med 2011.
- [7]Byakwaga H, Murray JM, Petoumenos K, et al.: Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression. AIDS Res Hum Retroviruses 2009, 25(6):756-776.
- [8]Robbins GK, Spritzler JG, Chan ES, et al.: Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis 2009, 48(3):350-361.
- [9]Florence E, Lundgren J, Dreezen C, et al.: Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med 2003, 4(3):255-62.
- [10]Beq S, Nugeyre MT, Ho Tsong Fang R, et al.: IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy. J Immunol 2006, 176:914-922.
- [11]Sereti I, Dunham RM, Spritzler J, et al.: IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009, 113:6304-6314.
- [12]Hellerstein MK, Hoh RA, Hanley MB, et al.: Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 2003, 112:956-966.
- [13]Chomont N, El-Far M, Ancuta P, et al.: HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009, 15:893-900.
- [14]MacPherson PA, Fex C, Sanchez-Dardon J, et al.: Interleukin-7 receptor expression on CD8+ T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr 2001, 28:454.
- [15]Paiardini M, Cervasi B, Albrecht H, et al.: Loss of CD127 expression defines an expansion of effector CD8+ T Cells in HIV-infected individuals. J Immunol 2005, 174:2900-2909.
- [16]Nemes E, Lugli E, Nasi M, et al.: Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. AIDS 2006, 20:2021-2032.
- [17]Benito JM, López M, Lozano S, Gonzalez-Lahoz J, Soriano V: Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy. J Infect Dis 2008, 198(10):1466-1473.
- [18]Colle JH, Moreau JL, Fontanet A, Lambotte O, Delfraissy JF, Thèze J: The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients. AIDS 2007, 21(1):101-103.